Value through Innovation27 July 2016

Clinical Study Results

  • BUSCOFEN ® - Healthy
    Clinical Study Number 1024.7
    Study Indication Healthy
    Product BUSCOFEN ®
    Generic Name Ibuprofen
    Lab Code
    Clinical Phase I
    Study Title

    Bioequivalence of a fixed-dose combination tablet containing 200 mg ibuprofen and 30 mg pseudoephedrine HCl compared to RhinAdvil® (200 mg ibuprofen and 30 mg pseudoephedrine HCl) as a fixed-dose combination tablet administered in healthy male and female volunteers (open-label, randomised, single dose, two-way crossover, Phase I trial)

    Study Document Trial synopsis 1024.7_DR english
  • BUSCOFEN ® - Healthy
    Clinical Study Number 1024.3
    Study Indication Healthy
    Product BUSCOFEN ®
    Generic Name Ibuprofen
    Lab Code
    Clinical Phase I
    Study Title

    An open two-way cross-over study to evaluate the relative bioavailability of lbuprofen enantiomers after single p.o. administration of 200 mg syrup (T) compared with 200 mg standard Brufen® syrup (R).

    Study Document Trial synopsis 1024.3 english
  • BUSCOFEN ® - Healthy
    Clinical Study Number 1024.5
    Study Indication Healthy
    Product BUSCOFEN ®
    Generic Name Ibuprofen
    Lab Code
    Clinical Phase I
    Study Title

    Open-label, randomised, single dose, four-way crossover study to investigate the relative bioavailability of a 400 mg ibuprofen extrudate tablet compared to a 400 mg ibuprofen lysinate tablet (Dolormin extra®) and a 400 mg ibuprofen tablet (Brufen® 400 mg, Denmark), in fasted condition and after ingestion of a standardised meal in healthy male and female volunteers

    Study Document Trial synopsis 1024.5 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.